Acorah Software Products - Accounts Production 19.3.550 false true true 31 July 2024 1 August 2023 false 1 August 2024 31 July 2025 31 July 2025 08404190 Mr William Rose Mr John Cusick William Rose true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 08404190 2024-07-31 08404190 2025-07-31 08404190 2024-08-01 2025-07-31 08404190 frs-core:Non-currentFinancialInstruments 2025-07-31 08404190 frs-core:ShareCapital 2025-07-31 08404190 frs-core:RetainedEarningsAccumulatedLosses 2025-07-31 08404190 frs-bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 08404190 frs-bus:FilletedAccounts 2024-08-01 2025-07-31 08404190 frs-bus:SmallEntities 2024-08-01 2025-07-31 08404190 frs-bus:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 08404190 frs-bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 08404190 1 2024-08-01 2025-07-31 08404190 frs-bus:Director1 2024-08-01 2025-07-31 08404190 frs-bus:Director2 2024-08-01 2025-07-31 08404190 frs-countries:EnglandWales 2024-08-01 2025-07-31 08404190 2023-07-31 08404190 2024-07-31 08404190 2023-08-01 2024-07-31 08404190 frs-core:CurrentFinancialInstruments 2024-07-31 08404190 frs-core:Non-currentFinancialInstruments 2024-07-31 08404190 frs-core:ShareCapital 2024-07-31 08404190 frs-core:RetainedEarningsAccumulatedLosses 2024-07-31
Stent (International) Limited
Unaudited Financial Statements
For The Year Ended 31 July 2025
Stent (International) Limited
Contents
Contents

| Page
--- | ---
Balance Sheet | 1
Notes to the Financial Statements | 2

Page 1
Stent (International) Limited
Balance Sheet
As At 31 July 2025
Balance Sheet
Registered number: 08404190

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
Creditors: Amounts Falling Due Within One Year | 4 | - |  | (60,246 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | - |  | (60,246 )
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | - |  | (60,246 )
Creditors: Amounts Falling Due After More Than One Year | 5 |  | (511,420 ) |  | (451,140 )
NET LIABILITIES |  |  | (511,420 ) |  | (511,386 )
CAPITAL AND RESERVES
Called up share capital | 6 |  | 100 |  | 100
Profit and Loss Account |  |  | (511,520 ) |  | (511,486 )
SHAREHOLDERS' FUNDS |  |  | (511,420) |  | (511,386)

For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Mr William Rose Director
11/06/2026

The notes on page 2 form part of these financial statements.
Page 1
Page 2
Stent (International) Limited
Notes to the Financial Statements
For The Year Ended 31 July 2025
Notes to the Financial Statements
1. General Information
Stent (International) Limited is a private company, limited by shares, incorporated in England & Wales, registered number 08404190. The registered office is 10 Carlton Close, London, NW3 7UA.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Going Concern Disclosure
The company is still trying to source projects within its field of expertise but is reliant on the co-operation of its major creditors to continue its operation.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
4. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Directors' loan accounts | - |  | 60,246

All loans are now treated as Long Term Loans falling within 5 years
5. Creditors: Amounts Falling Due After More Than One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Other creditors | 125,000 |  | 125,000
Directors' loan account | 60,246 |  | -
Amounts owed to related parties | 326,174 |  | 326,140
| 511,420 |  | 451,140

All loans as at the balance sheet date are now classified as long term loans subject to the company trading and producing trading profits which will then be used to repay the long term loans. It is hoped that repayment will be possible over the next 5 years
6. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 100 |  | 100

7. Ultimate Controlling Party
The company's ultimate controlling party is William Rose by virtue of his ownership of 100% of the issued share capital in the company
Page 2